Office-Based Buprenorphine: Patient Selection, Induction, and Management
The first in a series of 12 monthly webinars designed to support the implementation of Medication Assisted Treatment (MAT) in primary care. We will address the spectrum of needs including clinician needs, systems of care and regulatory/legal milieu. Our first webinar will focus on practical issues of induction on buprenorphine, including evaluating if the patient is appropriate for office-based opioid treatment (OBOT), factors that inform the decision around home or office-based inductions and the basics of inductions from methadone and other long-acting opioids. This webinar is designed to dovetail with an earlier CSAM webinar covering buprenorphine induction basics.
ASAM and/or CSAM Members: Free
You must register on this site before purchasing using the link on the upper right corner of this page. Only after registering will you see the "Add to Cart" button. To purchase, scroll to the bottom of the page and choose your purchase option (member/non-member) and click "Add to Cart."
This enduring internet activity is jointly provided by the California Society of Addiction Medicine (CSAM) and the California Health Care Foundation. CSAM is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™ Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
PA’s, nurses, pharmacists, psychologists and therapists can earn CEU credit.
- Primary Care Physician who are beginning or planning to integrate buprenorphine for the treatment of opioid dependence into theit practice.
- Associated health professionals who work in a setting that treats opioid dependent patients.
Soraya Azari, MD
Assistant Professor, Department of Medicine, UCSF School of Medicine
Dr. Azari and the planning group for this workshop have no relevant financial relationships to disclose.
- 1.00 Attendance
- 1.00 AMA Category 1
- Decide between of home- versus office-based induction for patients with opioid use disorders;
- Induce a patient from methadone or long-acting opioids to buprenorphine;
- Identify clinical features that make a patient more appropriate for methadone maintenance versus OBOT